|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.13(B) |
Last
Volume: |
742,051 |
Avg
Vol: |
474,459 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
3 |
6 |
6 |
8 |
Total Sell Transactions |
5 |
11 |
16 |
28 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Girshick Birgit |
Corporate Executive VP & COO |
|
2024-05-27 |
4 |
D |
$217.21 |
$52,565 |
D/D |
(242) |
47,022 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-05-27 |
4 |
D |
$217.21 |
$28,672 |
D/D |
(132) |
3,689 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-05-26 |
4/A |
D |
$217.21 |
$38,446 |
D/D |
(177) |
3,858 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2024-05-26 |
4 |
D |
$217.21 |
$39,098 |
D/D |
(180) |
13,336 |
|
- |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2024-05-26 |
4 |
D |
$217.21 |
$46,049 |
D/D |
(212) |
7,795 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-05-26 |
4 |
D |
$217.21 |
$10,861 |
D/D |
(50) |
7,775 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-05-26 |
4 |
D |
$217.21 |
$52,782 |
D/D |
(243) |
23,033 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-05-26 |
4 |
D |
$217.21 |
$36,491 |
D/D |
(168) |
6,939 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2024-05-26 |
4 |
D |
$217.21 |
$81,671 |
D/D |
(376) |
47,264 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-05-26 |
4 |
D |
$217.21 |
$38,446 |
D/D |
(177) |
3,821 |
|
- |
|
Massaro George |
Director |
|
2024-05-15 |
4 |
AS |
$234.72 |
$78,225 |
D/D |
(332) |
5,855 |
|
-10% |
|
Massaro George |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
6,187 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
7,894 |
|
- |
|
Andrews Nancy C |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
3,018 |
|
- |
|
Wilson Virginia M |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
3,965 |
|
- |
|
Bertolini Robert J |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$217,675 |
D/D |
953 |
32,802 |
|
- |
|
Thompson Craig B. |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
1,467 |
|
- |
|
Kemps-Polanco Reshema |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$192,778 |
D/D |
844 |
1,014 |
|
- |
|
Llado George |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$197,575 |
D/D |
865 |
3,349 |
|
- |
|
Mackay Martin |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$212,650 |
D/D |
931 |
12,531 |
|
- |
|
Wallman Richard F |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$232,750 |
D/D |
1,019 |
23,547 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-05-10 |
4 |
S |
$226.97 |
$295,969 |
D/D |
(1,304) |
23,276 |
|
9% |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2024-05-02 |
4 |
D |
$232.69 |
$207,792 |
D/D |
(893) |
8,007 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4/A |
S |
$267.52 |
$216,156 |
D/D |
(808) |
7,825 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4/A |
OE |
$267.52 |
$216,156 |
D/D |
808 |
8,633 |
|
- |
|
2064 Records found
|
|
Page 2 of 83 |
|
|